GlassScriptPhysician profile
Ricardo Salinas
NPI 1811511876
$2,559.57
in general payments reported to CMS, 2019-2025
19 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $249 · 2022: $443 · 2023: $781 · 2024: $583 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,867.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $633.30 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $380.84 | 2022-2025 | Farxiga, Andexxa |
| Novo Nordisk INC | $286.61 | 2022-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $241.89 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.17 | 2022-2024 | Jardiance |
| Abbott Laboratories | $129.73 | 2024-2025 | Freestyle Libre 3 |
| Amgen INC. | $126.19 | 2021-2025 | Repatha, Otezla, Evenity |
| Janssen Pharmaceuticals, INC | $121.82 | 2023-2024 | Xarelto |
| Dexcom, INC. | $115.54 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $81.69 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $66.93 | 2021-2022 | |
| Genentech USA, INC. | $55.96 | 2021 | |
| Astellas Pharma US INC | $36.81 | 2021 | |
| Sumitomo Pharma America, INC. | $32.08 | 2025 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.17 | 2021-2024 | Xifaxan |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $25.59 | 2024 | Inspire |
| Otsuka America Pharmaceutical, INC. | $21.40 | 2023 | Rexulti |
| Allergan, INC. | $18.88 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Salinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.